Immunovant halts development of its lead drug candidate, imeroprubart, in skin lupus following a trial miss.

The latest company to spin out of a Stanford Medicine lab is a biotech undertaking with 37,000 employees—and none of them are ...

The Global AI in Clinical Trials Market was valued at USD 2 Billion in 2025 and is projected to grow at a 15.5% CAGR from 2026 to 2034, reaching USD 7.32 Billion by 2034, according to Maximize Market ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Researchers developed a ‘virtual biotech’ made up of as many as 37,000 agents reporting to an 'chief scientist'.

The finding suggests Annamycin may do more than kill cancer cells directly; it may also expose tumors that are typically considered immunologically ?cold? to immune attack. Pancreatic cancer is among ...

After decades of hard-won progress, ALS drug development is entering a new era, building on established efficacy measures like survival and ALSFRS-R with biology-driven science that captures the full ...

InnoCare's pact with Eli Lilly, potentially worth up to US$3.35 billion, highlights a shift towards bigger partnerships, analysts say Chinese biotech deal making is moving beyond the licensing of ...

This study presents an innovative approach that combines quality by design (QbD) principles with artificial neural networks (ANNs) to predict and optimize the formulation of carbopol-based emulsions.

New Taipei City, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...